CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Randomized, Open-Label, Single-Dose, Five-Way Crossover Study to Compare the Pharmacokinetics of Asp-001, 2 Mg And 5 Mg Orally Disintegrating Tablets (Formulations A And B) With Sibelium® 5 Mg Tablet in Healthy Participants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07445464
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:19.165112+00:00
Published At: 2026-03-03T00:00:00+00:00
Record Updated At: 2026-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pharmacokinetic Analysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-03"
protocolSection.identificationModule.nctId: "NCT07445464"
protocolSection.identificationModule.officialTitle: "A Phase 1, Randomized, Open-Label, Single-Dose, Five-Way Crossover Study to Compare the Pharmacokinetics of Asp-001, 2 Mg And 5 Mg Orally Disintegrating Tablets (Formulations A And B) With Sibelium\u00ae 5 Mg Tablet in Healthy Participants"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.